Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROLEX: Paroxetine and Telaprevir Interaction in HCV
NCT01841502Phase 2Terminated
- Sponsor
- Radboud University Medical Center
- Start
- May 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of telaprevir in hepatitis C (HCV), sponsored by Radboud University Medical Center. Primary endpoint: Paroxetine Area Under the Curve at Day 14. Started May 2013; status: terminated.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01841502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01841502.